Abhishek Jha Received American Heart Association Postdoctoral Fellowship Award 2026-2027
The American Heart Association (AHA) is a globally recognized nonprofit organization dedicated to advancing cardiovascular, stroke, and brain health through research, education, and advocacy.
With a strong commitment to supporting scientific discovery and the next generation of investigators, AHA funds innovative research and competitive training programs worldwide.
Among these, the AHA Postdoctoral Fellowship Award recognizes promising early-career scientists and provides support for high-impact research that aligns with AHA’s mission to improve and save lives.
Abhishek Jha recently shared news of his latest achievement with Hemostasis Today.
“I am pleased to announce that I have been awarded a two-year American Heart Association Postdoctoral Fellowship (2026–2027).
My funded project, ‘Metabolic reprogramming to enhance hematoma resolution in intracerebral hemorrhage,’ will focus on advancing strategies to improve recovery following hemorrhagic stroke.
I am sincerely grateful to Dr. Anil Chauhan for his mentorship and for supporting my development as a scientist. I also extend my appreciation to my lab colleagues for their collaborative spirit, and to the senior investigators who kindly provided letters of support.
My heartfelt thanks to the American Heart Association and the review committee for recognizing the potential impact of this work and investing in its progress.
Best,
-Abhishek Jha
“The award amount has been kept hidden” – Abhishek Jha noted.
The AHA Postdoctoral Fellowship Award is a highly regarded, peer-reviewed fellowship that provides funding, mentorship, and national recognition to promising postdoctoral researchers in cardiovascular and cerebrovascular science.
For continued coverage and updates, visit Hemostasis Today.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly